The National Institute for Cannabis Investors says 2019 is shaping up to be the hottest year yet for CBD stocks.
The CBD market is already worth $591 million since CBD was legalized in the United States in December 2018. But the CBD market will skyrocket to $22 billion by 2022, according to the Brightfield Group.
That’s a whopping 3,623% bump in a little under three years.
STAKE YOUR CLAIM: Three pot stocks in particular could be poised for rare, wild gains of up to 1,000%. Click here to learn how you could see a $2 million “pot payday”…
That kind of growth is exactly why you need to invest in CBD stocks. In fact, it’s why Money Morning is all in on the cannabis industry.
But, before we show you our best CBD stocks to buy today, here’s why the cannabis industry is skyrocketing right now…
Here’s Why 2019 Is the Biggest Year for CBD Stocks
The biggest reason CBD has seen such explosive growth this year is because of the 2018 Farm Bill. The bill legalized the growth of hemp for CBD production on an industrial level.
This is a huge deal. Hemp is the easiest plant to produce CBD oil from. And since the legalization of CBD oil, it’s become a mainstream hit across American stores.
Healthline says CBD oil works with our bodies’ receptors to relieve pain. It’s proven to help certain conditions like epilepsy as well.
That’s led to a growth of new CBD products hitting the market. There are CBD lotions, CBD beverages, and CBD gummies in stores now. It’s even used as a salad dressing in some restaurants.
That’s why we’re bringing you the three best CBD stocks to buy today…
The Best CBD Stocks to Buy Today, No. 3: Cronos Group Inc.
Founded in 2013, Cronos is a Toronto-based cannabis company. And it’s one of the darlings of the marijuana industry.
Back in September, Cronos began expanding into CBD. In fact, thanks to its deal with Ginkgo Bioworks, Cronos has been able to create unique CBD products.
The $100 million deal between Cronos and Ginkgo meant the production of CBD in a different way. Instead of cultivation, Cronos inserted cannabinoid DNA sequences into yeast strains to ferment and create oil. The result is a lab-produced, high-quality, and pure CBD oil. The benefit of this is that the company can reliably produce rare CBD oils on an industrial scale with smaller operations.
And that’s one part of why Cronos Group has become such a hot commodity.
One of the world’s largest tobacco companies, Altria Group Inc. (NYSE: MO) invested $1.8 billion in cash into Cronos in March.
The extra cash gave Cronos the ability to buy other companies and increase its production. And this higher production meant more CBD products and bigger and better branding.
But don’t worry if you haven’t invested in Cronos Group yet, the stock is poised to surge even higher.
In Cronos’ Q1 2019, its revenue shot up to $4.83 million. That’s 120% year-over-year growth. But with $2.1 billion in cash from the Altria investment, Cronos still has massive growth potential.
And right now, Cronos has a market cap of $5.5 billion. This is in anticipation of its massive CBD rollout in Canada. And this is a big deal. The company will supply CBD beverages, oils, and creams across Canada.
Plus, Cronos will also be entering the U.S. market by the year’s end as well. The United States will see $22 billion in CBD sales over the next three years according to Brightfield Group.
Cronos Group shares currently trade for $15.92 per share. But its price target range says its poised to go as high as $19 within the year. That’s a 19% bump.
It even has a Money Morning VQScore™ of 3.75. This makes it a good buy right now. If it goes up to a 4, it’ll be an even better buy.
The Best CBD Stocks to Buy Today, No. 2: Canopy Growth Corp.
Founded in 2013, Canopy is an Ontario-based cannabis company and it’s one of the biggest cannabis companies in the world. But don’t worry, investors haven’t missed their opportunity to invest yet either.
Look at Amazon.com Inc. (NASDAQ: AMZN), for example. Between 1997 and 2000, Amazon’s share price similarly rocketed. In fact, it went from $2.44 to $81.50 in four years. That’s an insane 3,240% jump in share price.
But some investors were skeptical of investing in Amazon at $81.50 per share. But when you look back now, investing in Amazon at that price would have been an amazing decision.
In fact, its shares are now trading 2,242% higher at $1,909.09 per share.
There’s also Microsoft Corp. (NASDAQ: MSFT). In 2009, you would have thought it was too late to invest in the tech giant. But since then, its shares have skyrocketed over 700%.
And this could be the case with Canopy.
Rapper Snoop Dogg, actor Seth Rogen, even Martha Stewart are Canopy partners, too.
And its deal back in April is the biggest reason this CBD stock made our list today. In April, Canopy bought out Acreage Holdings Inc. (OTC: ACRG), the largest American cannabis operator.
That now makes Canopy the largest, with operations in over nine states. Some of these states include Colorado, California, Kentucky, North Carolina, Oregon, New York, Pennsylvania, Georgia, and Washington. This puts it in a prime position to sell CBD, cannabis, and more once it’s legalized across the United States.
In fact, its market cap is $14 billion with cannabis legal in 10 states. When cannabis is legalized across the United States, its stock could surge higher.
Canopy could double investor profits despite its massive growth between 2017 and now.
This CBD stock’s shares currently trade for $40.68. But it’s forecast to go as high as $78 over the next 12 months. That’s a massive 92% upside…
But our number one CBD stock could rocket even higher. In fact, it has a potential 163.3% upside…
The Best CBD Stocks to Buy Today, No. 1
Our top CBD stock to buy today is Aphria Inc. (NYSE: APHA).
Aphria is an Ontario-based cannabis company. It sells everything from marijuana to CBD oils. And this CBD stock is a great buy today because of its rapid growth. Between 2015 and 2018, its grown its revenue 6,595%.
Yet, its growth is far from over…
In a short time, it’s become one of the biggest cannabis producers in the world. In fact, by the end of 2019, the company reported it will produce roughly 250,000 kilograms of marijuana a year.
Plus, it’s one of four cannabis firms that supplies all 10 Canadian provinces. That means it’s selling recreational marijuana and CBD all across Canada.
It’s also partnered with Southern Glazer’s Wine and Spirits. This the biggest distributor of wine and spirits in North America. Through this partnership, Aphria can distribute its products throughout a continent-wide network.
Aphria is also securing its place on the international cannabis market. Back in April, the company received approval to cultivate marijuana in Germany. But it operates in 10 total medical cannabis markets worldwide, including in Europe and Latin America.
On top of that, its Q3 2019 net revenue was 240% higher than the same quarter last year. And it even has $80 million in cash.
Its shares currently trade for $7.05. But its target price range is $18.56. That’s a whopping 163.3% upside…
That, plus its international presence, makes Aphria our top CBD stock to buy today.
America’s Green Gold Rush Is Just Getting Started – Claim Your Stake Now
At this very moment, big investment firms and members of the Fortune 500 are building enormous war chests.
They’re preparing to push billions upon billions of dollars into the cannabis market – and they could strike at any moment. So right here – right now – you have a once-in-a-lifetime opportunity to beat them to the punch and stake your claim.
About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.
Disclaimer: © 2019 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.